Currently, fewer than one in five large employers are covering such prescriptions despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, according to a KFF analysis earlier ...
RBC Capital sees little reason for concern over CMS’ proposed GLP-1 coverage rule and its potential impact on MCOs. Should the rule go into effect in 2026 as proposed, plans would have adequate ...